GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
TECHSellZACKSHold
R500#465 today
$144.74
-1.87% today · -4.10% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- GILD −1.87% on the last session vs SPY +0.74%: −2.6 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
GILD against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #465 | -1.87% | +0.74% | |
| 1 week | #439 | -4.10% | -0.22% | |
| 1 month | #182 | -2.71% | +0.84% | |
| 3 months | #82 | +10.88% | +3.59% | |
| 6 months | #235 | +4.87% | +17.95% | |
| 1 year | #100 | +34.15% | +16.25% | |
| Overall | #240 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Drug Manufacturers - General
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | 0.13 | #354 | #2 |
| fPE/tPE | #1 | #1 | |
| PE/G | 2.15 | #369 | #3 |
| EV/Revenue | 6.59 | #132 | #4 |
| Gross Margin | 0.80 | #42 | #2 |
| Profit Margin | -0.11 | #476 | #9 |
| Revenue Growth | 0.10 | #228 | #2 |